Biophore applies for DCGI Emergency use approval of Aviptadil for COVID-19
365telugu.com,online,news,Hyderabad,12thJune,2021:Hyderabad-based Biophore India Pharmaceuticals has announced that it has applied for DCGI emergency use approval of Aviptadil Inhalation for marketing in India for the treatment of moderate to severe cases…